We are live on
!
Find out more
CMMB
Chemomab Therapeutics
CMMB
CMMB
17 hedge funds and large institutions have $4.07M invested in Chemomab Therapeutics in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
6% more funds holding
Funds holding: 16 → 17 (+1)
0.11% less ownership
Funds ownership: 0.36% → 0.25% (-0.11%)
46% less capital invested
Capital invested by funds: $7.53M → $4.07M (-$3.46M)
Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
8
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TSS
Two Sigma Securities
New York
|
+$38.8K |
| 2 |
VF
Virtu Financial
New York
|
+$28.7K |
| 3 |
Morgan Stanley
New York
|
+$22.4K |
| 4 |
GI
GAMMA Investing
Foster City,
California
|
+$10.4K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$7.01K |
Top Sellers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$551K |
| 2 |
YLHM
Yelin Lapidot Holdings Management
Tel Aviv,
Israel
|
-$291K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$20.4K |
